根據 位華爾街分析師的預測,Cbd Life Sciences Inc 的收入預期範圍從 $ 到 $
Cbd Life Sciences Inc 的盈利品質評分是多少?
Cbd Life Sciences Inc 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Cbd Life Sciences Inc 何時發布財報?
Cbd Life Sciences Inc 的下一份財報預計在 發布
Cbd Life Sciences Inc 的預期收益是多少?
根據華爾街分析師的預測,Cbd Life Sciences Inc 的預期收益為 $
Cbd Life Sciences Inc 是否超出收益預期?
Cbd Life Sciences Inc 最近的收益為 $, 預期。
關鍵數據
前收市價
$0.0001
開盤價
$0.0002
當日範圍
$0.0002 - $0.0002
52週區間
$0.0001 - $0.001
交易量
141.6K
平均成交量
9.4M
股息收益率
--
每股盈餘 (TTM)
--
市值
$4.8M
什麼是 CBDL?
CBD Life Sciences, Inc. focuses on identifying, evaluating and acquiring undervalued opportunities with the objective of increasing shareholder value. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2013-08-12. Its discovery and reporting process designed for the health care industry. The firm is focused on hospitals, nursing homes and doctor’s offices. The firm assists in protecting these organizations in protecting from cyber threats, such as the theft of patient medical records and manipulation of medical devices.